CLINICAL OTOLARYNGOLOGY, cilt.40, sa.6, ss.622-628, 2015 (SCI-Expanded)
Objective: PI3K/Akt signalling pathway is frequently activated in several types of cancer. However, activator molecules have not been analysed systematically in HNSCC. The aim of this study was to investigate upstream activators and inhibitors of this pathway.